Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Changes include enhanced emphasis on the role of social and financial determinants in diabetes patient health.
Read More »Critical Changes to the 2021 ADA Standards of Care
PK/PD of Glargine-300units/ml Compared to Degludec-100units/ml
Glargine and degludec had similar glycemic control with some differences in pharmacokinetics (PK) and pharmacodynamics (PD).
Read More »Risk of Advanced Liver Disease Doubled in Patients with Diabetes
Some metabolic factors, including type 2 diabetes, can increase the risk of severe non-alcoholic fatty liver disease (NAFLD).
Read More »Cause-Specific Mortality Due to Hypoglycemia
A retrospective observational study seeks to determine absolute risk of death due to CVD, cancer, and other causes in patients who experienced a severe hypoglycemic event.
Read More »The Role of Dapagliflozin in Patients with Type 2 Diabetes and Atrial Fibrillation
A post hoc analysis of the DECLARE-TIMI 58 trial may provide a new compelling indication for dapagliflozin.
Read More »Glycemic Benefit of Weekly GLP-1 Agonist: Albiglutide
Simple add-on therapy can reduce insulin use for patients with type 2 diabetes.
Read More »Major Reduction in Risk of Heart Attacks in Patients with Diabetes
Initiating the right medications upon diabetes diagnosis can help mitigate heart attack risk.
Read More »How Patients with T2DM Can Safely Consume Food with High Glycemic Index
A new study shows that a potato-based diet does not disturb blood sugar control in patients with type 2 diabetes mellitus (T2DM).
Read More »Gestational Diabetes and Related Outcomes in Singleton and Twin Pregnancies
Does gestational diabetes pose the same risks in twin pregnancies?
Read More »The Impact of Intensity Variation in Physical Activity on Mortality Rates
Does a higher percentage of vigorous physical activity as part of total exercise time confer additional benefits?
Read More »